ICKSH 2024

[JS03] Joint Session 03

ASH-KSH Joint Symposium - Ped-ALL

Room 1 (Vista Hall 1)

March 29 (Fri), 09:00-10:15
Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
Wendy Stock (University of Chicago, USA)
Pediatric and AYA ALL: Lessons learned from Childern's Onclogy Group clinical trials Sarah K. Tasian (The Children’s Hospital of Philadelphia, USA) Multicenter trials investigating childhood acute lymphoblastic leukemia in South Korea Hyery Kim (University of Ulsan College of Medicine, Korea) Dissecting the developmental origins of acute leukemia Charles G. Mullighan (St. Jude Children’s Research Hospital, USA) Unveiling precision medicine: RNA and DNA sequencing in targeted therapy for Korean pediatric leukemia Myungshin Kim (College of Medicine, The Catholic University of Korea, Korea)

[ES03] Education Session 03

Leaps and hurdles in transfusion medicine (Kor)

Room 2 (Vista Hall 2)

March 29 (Fri), 09:00-10:15
Duck Cho (Sungkyunkwan University School of Medicine, Korea)
Jihyang Lim (College of Medicine, The Catholic University of Korea, Korea)
Comprehensive overview of cell-based artificial platelet production Seung Yeob Lee (Jeonbuk National University Medical School, Korea) Anti-CD38 and anti-CD47 delay timely transfusion Hyungsuk Kim (Seoul National University College of Medicine, Korea) Reappraisal of transfusion-transmitted infections Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)

[SS09] Scientific Session 09

Clonal hematopoiesis: What should we know?

Room 3 (Grand Hall 1)

March 29 (Fri), 09:00-10:15
Myung Geun Shin (Chonnam National University Medical School, Korea)
Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
Clonal hematopoiesis and aging Siddhartha Jaiswal (Stanford University School of Medicine, USA) Clonal hematopoiesis: Implications for cell therapy Adam S. Sperling (Dana-Farber Cancer Institute, USA) Clonal hematopoiesis and metabolic diseases Sung Hee Choi (Seoul National University College of Medicine, Korea)

[SS10] Scientific Session 10

Predictive biomarkers in multiple myeloma

Room 4 (Art Hall)

March 29 (Fri), 09:00-10:15
Chang-Ki Min (College of Medicine, The Catholic University of Korea, Korea)
Jeong Yeal Ahn (Gachon University College of Medicine, Korea)
The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma Nizar Jacques Bahlis (University of Calgary, Canada) Single-cell techniques to characterize immune microenvironment in MM Niels Weinhold (Heidelberg University, Germany) The power of ONE: Immunology in the age of single cell genomics Ido Amit (Weizmann Institute of Science, Israel)

[PL02] Plenary Lecture 02

Plenary Lecture 02

Room 1 (Vista Hall 1)

March 29 (Fri), 10:30-11:15
Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
How to win: Competitive strategies in the hematopoietic stem cell niche Margaret Goodell (Baylor College of Medicine, USA)

[SY05] Satellite Symposium 05

BMS

Room 1 (Vista Hall 1)

March 29 (Fri), 12:15-13:05
Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Continued hope with ONUREG - A new maintenance therapy to treat AML Esther Oliva (Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Italy)

[SY06] Satellite Symposium 06

Kyowa Kirin

Room 2 (Vista Hall 2)

March 29 (Fri), 12:15-13:05
Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
Mogamulizumab: A new era in MF/SS management - Clinical evidence and practical consideration Francine Foss (Yale University School of Medicine, USA)

[SY07] Satellite Symposium 07

Novartis

Room 3 (Grand Hall 1)

March 29 (Fri), 12:15-13:05
Dong-Wook Kim (Eulji University School of Medicine, Korea)
TKI treatment pattern and new therapy of CML Qian Jiang (Peking University People's Hospital, China)

[SY08] Satellite Symposium 08

Handok

Room 4 (Art Hall)

March 29 (Fri), 12:15-13:05
Hyeon-Seok Eom (National Cancer Center, Korea)
The optimal treatment strategy for transplant-ineligible relapsed/refractory DLBCL Kwai Han Yoo (Gachon University College of Medicine, Korea)

[OP5] Oral Presentation 05

Acute leukemia - 2

Room 1 (Vista Hall 1)

March 29 (Fri), 13:20-14:50
Jeong-Ok Lee (Seoul National University College of Medicine, Korea)
Sung Han Kang (University of Ulsan College of Medicine, Korea)

[OP6] Oral Presentation 06

Multiple myeloma

Room 2 (Vista Hall 2)

March 29 (Fri), 13:20-14:50
Yeung-Chul Mun (Ewha Womans University College of Medicine, Korea)
Sung-Hoon Jung (Chonnam National University Medical School, Korea)
Carfilzomib, lenalidomide, dexamethasone in the real-world Asian relapsed and/or refractory multiple myeloma patients - KMM2201 study Ji Hyun Lee (Dong-A University College of Medicine, Korea) Real-world effectiveness of Ixazomib, lenalidomide, and dexamethasone (IRd) in Asian patients with relapsed/ refractory multiple myeloma (RRMM) Soo Chin Ng (Subang Jaya Medical Centre, Malaysia) Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus Ixazomib, lenalidomide, and dexa - methasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Do Young Kim (Pusan National University School of Medicine, Korea) Bortezomib maintenance therapy in transplant-ineligible newly diagnosed multiple myeloma have major response to induction chemotherapy (KMM 174) Jung Yeon Lee (College of Medicine, The Catholic University of Korea, Korea) Impact of pretransplant measurable residual disease(MRD) using multiparametric flow cytometry(mFCM) and imaging (PET-CT scan) before autologous stem cell transplantation(ASCT) in multiple myeloma : Insights from tertiary centre In India Rudra Nrayan Swain (Post Graduate Institute of Medical Education and Research, India) The efficacy of salvage second autologous hematopoietic stem cell transplantation in Korean patients with relapsed/refractory multiple myeloma in novel agent era: the KMM2301 study Jongheon Jung (National Cancer Center, Korea)

[OP7] Oral Presentation 07

Myeloid neoplasm & Bone marrow failure

Room 3 (Grand Hall 1)

March 29 (Fri), 13:20-14:50
Seong Hyun Jeong (Ajou University School of Medicine, Korea)
Ji Hyun Kwon (Chungbuk National University College of Medicine, Korea)
Efficacy & safety of momelotinib vs danazol in JAKi-experienced patients with myelofibrosis & anemia: Asian subgroup analysis of the MOMENTUM trial Sung-Soo Yoon (Seoul National University College of Medicine, Korea) Distinct molecular and cytogenetic profiles of myelodysplastic syndrome with bone marrow eosinophilia and basophilia Yujin Jung (Seoul National University College of Medicine, Korea) Clinical and molecular characteristics and prognostic significance of autoimmune disease in myelodysplastic syndrome Yunsuk Choi (University of Ulsan College of Medicine, Korea) Haploidentical HCT using ex vivo T cell-depleted PBSC as first-line therapy for pediatric patients with acquired SAA Ho Joon Im (University of Ulsan College of Medicine, Korea) STK10 mutation block erythropoiesis in acquired pure red cell aplasia via down-regulated the ribosome biosyn - thesis Meng Danchen (The First Affiliated Hospital of Anhui Medical University, China)

[OP8] Oral Presentation 08

Thrombocytopenia & Supportive care

Room 4 (Art Hall)

March 29 (Fri), 13:20-14:50
Junshik Hong (Seoul National University College of Medicine, Korea)
Seungmin Hahn (Yonsei University College of Medicine, Korea)
Clinical outcomes of TPO-receptor agonists in patients with steroid-refractory immune thrombocytopenia; Significant conditions of discontinuation with good response Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombo - cytopenia: A multicenter observational retrospective study in China Zhifa Wang (Beijing Children’s Hospital, China) Effect of anagrelide on health-related quality of life in patients with treatment-nave, high-risk essential thrombo - cythemia Taekeun Park (Seoul National University College of Medicine, Korea) Impact of hematopoietic stem cell transplantation on bone metabolism and growth in pediatric patients with thalassemia major Yu Liu (Shantou University, China) Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies Dong Hyun Kim (Seoul National University College of Medicine, Korea) The clinical manifestation, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hemato - poietic stem cell transplantation Yuewen Wang (Peking University People’s Hospital, China)

[JS04] Joint Session 04

Current interests in hematologic disease in Asia

Room 1 (Vista Hall 1)

March 29 (Fri), 15:05-16:20
Byeong-Bae Park (Hanyang University College of Medicine, Korea)
The journey of bone marrow transplantation at BachMai General Hospital Han Viet Trung (Bach Mai Hospital, Vietnam) Current situation of management of non-Hodgkin lymphoma in the Republic of Armenia Yervand Hakobyan (Armenian Hematology Association, Armenia) The evolution of hemophilia treatment in Thailand Darintr Sosothikul (Chulalongkorn University, Thailand)

[SS11] Scientific Session 11

Quality-of-life revisited

Room 2 (Vista Hall 2)

March 29 (Fri), 15:05-16:20
Sung Yong Oh (Dong-A University College of Medicine, Korea)
Yong Park (Korea University College of Medicine, Korea)
Palliative care for patients with leukemia Min Sun Kim (Seoul National University College of Medicine, Korea) Long-term survivorship in hematologic malignancies Shahrukh K. Hashmi (Mayo Clinic, UAE) The importance of monitoring symptoms and quality of life in routine hematology practice Fabio Efficace (Italian Group for Adult Hematologic Diseases, Italy)

[SS12] Scientific Session 12

Novel approaches for diagnosis & treatment of acute lymphoblastic leukemia

Room 3 (Grand Hall 1)

March 29 (Fri), 15:05-16:20
Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Ho-Jin Shin (Pusan National University School of Medicine, Korea)
Novel approaches for diagnosis & treatment of acute lymphoblastic and myeloid leukemia Michel Zwaan (Princess Máxima Center for Pediatric Oncology, The Netherlands) The role of blinatumomab in the treatment of MRD negative B-ALL in adults Mark R. Litzow (Mayo Clinic, USA) Revised WHO classification of ALL: New era of genetic diagnosis Ari Ahn (College of Medicine, The Catholic University of Korea, Korea)

[ES04] Education Session 04

Monoclonal gammopathies of clinical significance

Room 4 (Art Hall)

March 29 (Fri), 15:05-16:20
Young Rok Do (Keimyung University School of Medicine, Korea)
Hyo Jung Kim (Hallym University College of Medicine, Korea)
AL cardiac amyloidosis Darae Kim (Sungkyunkwan University School of Medicine, Korea) Nephrologist’s perspective on monoclonal gammopathy of renal significance Soon Hyo Kwon (Soonchunhyang University College of Medicine, Korea) Monoclonal gammopathies of neurological significance Ju-Hong Min (Sungkyunkwan University School of Medicine, Korea)

[SS13] Scientific Session 13

Advancing in knowledge of rare pediatric hematologic disorders

Room 2 (Vista Hall 2)

March 29 (Fri), 16:35-17:50
Ho Joon Im (University of Ulsan College of Medicine, Korea)
Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
Clonal evolution of MDS/AML in patients with cancer predisposition syndromes Kenichi Yoshida (National Cancer Center Research Institute, Japan) Congenital and aquired thrombophilic conditions in children Leonardo R. Brandão (University of Toronto, Canada) Management of rare pediatric lymphomas Jae Wook Lee (College of Medicine, The Catholic University of Korea, Korea)

[JS05] Joint Session 05

Asian Hematology Session II - AML

Room 3 (Grand Hall 1)

March 29 (Fri), 16:35-17:50
Sangkyun Sohn (Kyungpook National University School of Medicine, Korea)
Byong Soo Kim (Korea University College of Medicine, Korea)
Epidemiology, risk stratification and treatment outcome in acute myeloid treatment: Taiwan experience Hsin-An Hou (National Taiwan University, Taiwan) Advancement in leukaemia diagnostics: The role of next-generation sequencing (NGS) in acute myeloid leukae - mia in Malaysia Angeli Ambayya (Ministry of Health, Malaysia) Determining fitness for treatments in older adults with AML Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea)

[ES05] Education Session 05

Principles of anticoagulation - All about blood clots (Kor)

Room 4 (Art Hall)

March 29 (Fri), 16:35-17:50
Soo-Mee Bang (Seoul National University College of Medicine, Korea)
Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea)
Back to the basic: Coagulation pathway Seonyang Park (Inje University College of Medicine, Korea) Pharmacology: Anticoagulants and reversal agents Seo-Yeon Ahn (Chonnam National University Medical School, Korea) Proper application of anticoagulation therapy on cancer associated thrombosis Ho-Young Yhim (Jeonbuk National University Medical School, Korea)

Scientific Program

Sponsored by